|
 |
�뜑 吏㏐쾶, �뜑 源딄쾶: 洹쇰Т�떆媛� �쁺�떊�씠 |
|
| 2025�뀈 諛쒗몴�맂 Nature Human Behaviour �뿰援щ뒗 6媛쒓뎅, 141媛� 湲곗뾽, �빟 2,900紐낆쓽 吏곸썝�쓣 ����긽�쑝濡� 6媛쒖썡媛� 二� 4�씪 洹쇰Т�젣瑜� �떆踰� �룄�엯�븳 寃곌낵瑜� 遺꾩꽍�뻽�떎. 洹� 寃곌낵�뒗 �삁�긽蹂대떎 �뜑 洹뱀쟻�씠�뿀�떎. 洹쇰Т �떆媛꾩씠 以꾩뿀吏�留�, "�뾽臾� �슚�쑉�꽦怨� 吏묒쨷�룄�뒗 �삤�엳�젮 利앷��"�뻽�떎. |
|
|
 |
The Biogenerics Mark |
|
| Everyone is familiar with generic drugs that were once proprietary. As soon as the patent runs out, companies rush in with their version of a popular drug. |
|
|
 |
�굹�뒗 �넻利� �뾾�씠 �궛�떎 |
|
| 저자 | �넚誘몄뿰 �쇅 |
| 출판사 | 鍮꾪��遺곸뒪 |
|
 |
Front Row at the Tru |
|
| 저자 | Jonathan Karl |
| 출판사 | Dutton |
|
 |
Think Again |
|
| 저자 | Sydney Finkelstein �쇅 |
| 출판사 | Harvard Business School Press |
|
[496]권 
